BTAX

Biostax Corp. BTAX

BTAX
Biostax Corp. REPCF
RepliCel Life Sciences Inc. STAB
Statera Biopharma, Inc. HSTC
HST Global, Inc. RCAR
RenovaCare, Inc. ARDS
Aridis Pharmaceuticals, Inc. GSRX
GSRX Industries Inc. INFIQ
Infinity Pharmaceuticals, Inc. PANC
Panacos Pharmaceuticals, Inc. DNAG
DNAPrint Genomics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BTAX REPCF STAB HSTC RCAR ARDS GSRX INFIQ PANC DNAG
6M -50.00 % -95.00 % 0.00 % -99.96 % 0.00 % 100.00 % 0.00 % 900.00 % 0.00 % -90.00 %
YTD -99.37 % -90.00 % 0.00 % -99.98 % 0.00 % 100.00 % 0.00 % 900.00 % 0.00 % 900.00 %
1Y -99.71 % -97.67 % -50.00 % -99.98 % 0.00 % 100.00 % 0.00 % 0.00 % 0.00 % 900.00 %
3Y -99.99 % -98.88 % -99.95 % -99.84 % -99.81 % -99.98 % 0.00 % -99.99 % 900.00 % 900.00 %
5Y -100.00 % -99.01 % -100.00 % -99.80 % -100.00 % -100.00 % -99.83 % -99.99 % 900.00 % -99.00 %
10Y -100.00 % -99.96 % -100.00 % -99.37 % -99.99 % -100.00 % -99.99 % -100.00 % 9 900.00 % -99.00 %
From the beginning -100.00 % -99.94 % -100.00 % -100.00 % -99.99 % -100.00 % -99.95 % -100.00 % -99.99 % -100.00 %

Dividend